Buy or sell Human Longevity stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

Human Longevity Stock

Genomics and cell therapy



Notable Investors



San Diego CA, US

Total Funding


About Human Longevity Stock

Human Longevity, Inc. (HLI) is the genomic-based, health intelligence company empowering proactive healthcare and enabling a life better lived. HLI combines the largest database of genomic and phenotypic data with machine learning to drive discoveries and revolutionize the practice of medicine. HLI’s business areas include the HLI Health Nucleus, a genomic powered clinical research center which uses whole genome sequence analysis, advanced clinical imaging and innovative machine learning, along with curated personal health information, to deliver the most complete picture of individual health; HLIQ™ Whole Genome and HLIQ Oncology.


Funding History

June 2019$36.4M
June 2019$18.0M


Co-Founder & CEO

J. Venter

Co-Founder & Vice Chairman

Robert Hariri

Chief Information Officer

Yaron Turpaz

Medical Director

Brad Perkins


EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 300K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: